KAKelly K. Andringa

Kelly K. Andringa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kelly K. Andringa has a total of 89 co-authors. Here are the top co-authors by number of shared publications:

  • Shannon M. Bailey

    Department of Environmental Health Sciences, University of Alabama at Birmingham, Birmingham, Alabama

    8 shared publications
  • Adrienne L. King

    Department of Environmental Health Sciences, University of Alabama at Birmingham, Birmingham, Alabama

    4 shared publications
  • Heather B. Eccleston

    Department of Environmental Health Sciences, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA

    4 shared publications
  • Sudheer K. Mantena

    Department of Environmental Health Sciences, University of Alabama at Birmingham, Birmingham, Alabama

    4 shared publications
  • Aimee Landar

    Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

    3 shared publications
  • Anupam Agarwal

    Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA

    3 shared publications

Latest Publications

  • Proceedings of the 10th Annual UAB-UCSD O’Brien Center Symposium: Changing Paradigms in Acute Kidney Injury: From Mechanisms to Management

    by Kelly K. Andringa

    Acute kidney injury (AKI) can occur within hours or up to a few days and consists of a sudden onset of kidney damage that leads to organ failure, inappropriate fluid balance in the body and multiple subsequent medical issues. Thus, research to further understanding of the mechanisms, causes and other organ effects of AKI is important and valuable to both the medical community as well as the patient population for which this research is directed. This issue summarizes the proceedings of the 10th annual symposium that was sponsored by the University of Alabama at Birmingham (UAB) – University of California San Diego (UCSD) O’Brien Center for Acute Kidney Injury Research and held during the 25th annual Continuous Renal Replacement Therapy conference in San Diego, California on February 24, 2020.


  • Open Access

    Changing Paradigms in Acute Kidney Injury: From Mechanisms to Management: Proceedings of the 9th Annual UAB-UCSD O’Brien Center Symposium

    by Kelly K. Andringa, Ravindra L. Mehta, Paul W. Sanders, Anupam Agarwal

    Acute kidney injury (AKI) is the sudden onset of kidney failure or kidney damage that occurs within hours or up to a few days. This causes immediate buildup of waste products in the blood and leads to the inability to maintain appropriate fluid balance in the body. The recent research surrounding this disease state has attempted to further detail the mechanisms of AKI, how they affect other organ systems but has also been focused on therapeutic and preventative strategies for AKI. Preventative strategies have come to the forefront through the interest in precision medicine and how it can best be utilized in AKI. Targets for cellular and physiological intervention have also been involved in the research in this field as well as other disease states that lead to AKI in patient populations. This issue summarizes the proceedings of the 9th annual symposium that was sponsored by the University of Alabama at Birmingham-University of California San Diego O’Brien Center for AKI Research and held during the 24th annual Continuous Renal Replacement Therapy conference in San Diego, California, on February 26, 2019.

  • Open Access

    Changing Paradigms in Acute Kidney Injury: From Mechanisms to Management: Proceedings of the 8th Annual UAB-UCSD O’Brien Center Symposium

    by Kelly K. Andringa, Ravindra L. Mehta, Paul W. Sanders, Anupam Agarwal

    Acute kidney injury (AKI) is an occurrence of kidney failure/damage that can happen within hours to a few days. The research surrounding this disease state has rapidly evolved to elucidate further the mechanisms and pathways of AKI and how these affect other organ systems and processes. Biomarkers and other small molecules have provided new tools and techniques to further characterize AKI, including genetic and epigenetic modifications, environmental influences, and the mechanisms within the kidney. Further understanding the pathophysiology of AKI offers challenging perspectives in clinical and translational research. This issue summarizes the proceedings of the 8th annual symposium that was sponsored by the University of Alabama at Birmingham (UAB) – University of California San Diego (UCSD) O’Brien Center for AKI Research and held during the 23rd annual Continuous Renal Replacement Therapy conference in San Diego, California on March 6, 2018.

  • Open Access

    The methyl donor S-adenosylmethionine prevents liver hypoxia and dysregulation of mitochondrial bioenergetic function in a rat model of alcohol-induced fatty liver disease

    by Adrienne L. King, Sudheer K. Mantena, Kelly K. Andringa, Telisha Millender-Swain, Kimberly J. Dunham-Snary, Claudia R. Oliva, Corinne E. Griguer, Shannon M. Bailey


  • Role of Hypoxia-Inducible Factors in Acute Kidney Injury

    by Kelly K. Andringa, Anupam Agarwal

    Oxygen is vital to mammalian survival. Oxygen deprivation, defined as hypoxia, elicits adaptive responses in cells and tissues, a process regulated by proteins known as hypoxia-inducible factors (HIF). Animal studies have provided compelling data to demonstrate a pivotal role for the HIF pathway in the pathogenesis of acute kidney injury (AKI) that have led to initial human clinical trials examining this pathway in ischemia-reperfusion injury in various organ systems, including the kidney. HIF are master regulators and mediate adaptive responses to low oxygen in tissues and cells. This review will summarize recent key advances in the field highlighting preclinical and clinical studies relevant to the HIF pathway in the pathophysiology of AKI.


  • Open Access

    Proteomic analysis of 4-hydroxynonenal (4-HNE) modified proteins in liver mitochondria from chronic ethanol-fed rats

    by Kelly K. Andringa, Uduak S. Udoh, Aimee Landar, Shannon M. Bailey


  • Open Access

    Ozone inhalation modifies the rat liver proteome

    by Whitney S. Theis, Kelly K. Andringa, Telisha Millender-Swain, Dale A. Dickinson, Edward M. Postlethwait, Shannon M. Bailey


  • Top Cited Papers
    Open Access

    End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1

    by Barry I. Freedman, Carl D. Langefeld, Kelly K. Andringa, Jennifer A. Croker, Adrienne H. Williams, Neva E. Garner, Daniel J. Birmingham, Lee A. Hebert, Pamela J. Hicks, Mark S. Segal, et al.

    Objective: Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE) that exhibits familial aggregation and may progress to end‐stage renal disease (ESRD). LN is more prevalent among African Americans than among European Americans. This study was undertaken to investigate the hypothesis that the apolipoprotein L1 gene (APOL1) nephropathy risk alleles G1/G2, common in African Americans and rare in European Americans, contribute to the ethnic disparity in risk.Methods: APOL1 G1 and G2 nephropathy alleles were genotyped in 855 African American SLE patients with LN‐ESRD (cases) and 534 African American SLE patients without nephropathy (controls) and tested for association under a recessive genetic model, by logistic regression.Results: Ninety percent of the SLE patients were female. The mean ± SD age at SLE diagnosis was significantly lower in LN‐ESRD cases than in SLE non‐nephropathy controls (27.3 ± 10.9 years versus 39.5 ± 12.2 years). The mean ± SD time from SLE diagnosis to development of LN‐ESRD in cases was 7.3 ± 7.2 years. The G1/G2 risk alleles were strongly associated with SLE‐ESRD, with 25% of cases and 12% of controls having 2 nephropathy alleles (odds ratio [OR] 2.57, recessive model P = 1.49 × 10−9), and after adjustment for age, sex, and ancestry admixture (OR 2.72, P = 6.23 × 10−6). The age‐, sex‐, and admixture‐adjusted population attributable risk for ESRD among patients with G1/G2 polymorphisms was 0.26, compared to 0.003 among European American patients. The mean time from SLE diagnosis to ESRD development was ∼2 years earlier among individuals with APOL1 risk genotypes (P = 0.01).Conclusion: APOL1 G1/G2 alleles strongly impact the risk of LN‐ESRD in African Americans, as well as the time to progression to ESRD. The high frequency of these alleles in African Americans with near absence in European Americans explains an important proportion of the increased risk of LN‐ESRD in African Americans.


  • Chronic Exposure to a High-Fat Diet Induces Hepatic Steatosis, Impairs Nitric Oxide Bioavailability, and Modifies the Mitochondrial Proteome in Mice

    by Heather B. Eccleston, Kelly K. Andringa, Angela M. Betancourt, Adrienne L. King, Sudheer K. Mantena, Telisha M. Swain, Heather N. Tinsley, Ryan N. Nolte, Tim R. Nagy, Gary A. Abrams, et al.

    Obesity-related pathologies, such as nonalcoholic fatty liver disease, are linked to mitochondrial dysfunction and nitric oxide (NO) deficiency. Herein, we tested the hypothesis that a high-fat diet (HFD) modifies the liver mitochondrial proteome and alters proteins involved in NO metabolism, namely arginase 1 and endothelial NO synthase. Male C57BL/6 mice were fed a control or HFD and liver mitochondria were isolated for proteomics and reactive oxygen species measurements. Steatosis and hepatocyte ballooning were present in livers of HFD mice, with no pathology observed in the controls. HFD mice had increased serum glucose and decreased adiponectin. Mitochondrial reactive oxygen species was increased after 8 weeks in the HFD mice, but decreased at 16 weeks compared with the control, which was accompanied by increased uncoupling protein 2. Using proteomics, 22 proteins were altered as a consequence of the HFD. This cohort consists of oxidative phosphorylation, lipid metabolism, sulfur amino acid metabolism, and chaperone proteins. We observed a HFD-dependent increase in arginase 1 and decrease in activated endothelial NO synthase. Serum and liver nitrate + nitrite were decreased by HFD. In summary, these data demonstrate that a HFD causes steatosis, alters NO metabolism, and modifies the liver mitochondrial proteome; thus, NO may play an important role in the processes responsible for nonalcoholic fatty liver disease. Antioxid. Redox Signal. 15, 447–459.


  • Developmental Exposure to Environmental Tobacco Smoke increases Atherogenesis and alters Mitochondrial DNA Copy Number and Proteomics

    by Jessica L. Fetterman, Melissa Pompilius, David Westbrook, Kelly Andringa, Shannon Bailey, Dale Uyeminami, Kent E. Pinkerton, Scott W. Ballinger